RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies - PubMed (original) (raw)

• RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study.
  Le Calvez-Kelm F, Oliver J, Damiola F, Forey N, Robinot N, Durand G, Voegele C, Vallée MP, Byrnes G, Registry BC, Hopper JL, Southey MC, Andrulis IL, John EM, Tavtigian SV, Lesueur F. Le Calvez-Kelm F, et al. PLoS One. 2012;7(12):e52374. doi: 10.1371/journal.pone.0052374. Epub 2012 Dec 27. PLoS One. 2012. PMID: 23300655 Free PMC article.
• Breast cancer risks and risk prediction models.
  Engel C, Fischer C. Engel C, et al. Breast Care (Basel). 2015 Feb;10(1):7-12. doi: 10.1159/000376600. Breast Care (Basel). 2015. PMID: 25960719 Free PMC article. Review.
• Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.
  Bonaïti B, Bonadona V, Perdry H, Andrieu N, Bonaïti-Pellié C. Bonaïti B, et al. Eur J Hum Genet. 2011 Feb;19(2):173-9. doi: 10.1038/ejhg.2010.158. Epub 2010 Oct 6. Eur J Hum Genet. 2011. PMID: 20924409 Free PMC article.
• Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.
  Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghoussaini M, Moradi Marjaneh M, Jiang X, Agata S, Aittomäki K, Alonso MR, Andrulis IL, Anton-Culver H, Antonenkova NN, Arason A, Arndt V, Aronson KJ, Arun BK, Auber B, Auer PL, Azzollini J, Balmaña J, Barkardottir RB, Barrowdale D, Beeghly-Fadiel A, Benitez J, Bermisheva M, Białkowska K, Blanco AM, Blomqvist C, Blot W, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borg A, Bosse K, Brauch H, Brenner H, Briceno I, Brock IW, Brooks-Wilson A, Brüning T, Burwinkel B, Buys SS, Cai Q, Caldés T, Caligo MA, Camp NJ, Campbell I, Canzian F, Carroll JS, Carter BD, Castelao JE, Chiquette J, Christiansen H, Chung WK, Claes KBM, Clarke CL; GEMO Study Collaborators; EMBRACE Collaborators; Collée JM, Cornelissen S, Couch FJ, Cox A, Cross SS, Cybulski C, Czene K, Daly MB, de la Hoya M, Devilee P, Diez O, Ding YC, Dite GS, Domchek SM, Dörk T, Dos-Santos-Silva I, Droit A, Dubois S, Dumont M, Duran M, Durcan L, Dwek M, Eccles DM, Engel C, Eriksson M, Evans DG, Fasching PA, Fletcher O, Floris G, Flyger H, Foretova L, Foulkes WD, Friedman E, Fritschi L, Frost D… See abstract for full author list ➔ Fachal L, et al. Nat Genet. 2020 Jan;52(1):56-73. doi: 10.1038/s41588-019-0537-1. Epub 2020 Jan 7. Nat Genet. 2020. PMID: 31911677 Free PMC article.
• ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.
  Akisik E, Yazici H, Dalay N. Akisik E, et al. Mol Biol Rep. 2011 Jan;38(1):343-8. doi: 10.1007/s11033-010-0113-3. Epub 2010 Apr 1. Mol Biol Rep. 2011. PMID: 20358297